Content matching 'Investigational New Drug'
U.S. Stem Cell Clinics and International Businesses Are Registering For-Profit, Pay-to-Participate “Studies” on ClinicalTrials.gov
The cohort of companies developing products for treating cancer with genetically engineered T-cells has increased with the announcement that Merck Serono and Intrexon Corp will collaborate to generate new drug candidates using the technology.
Research by Douglas Melton of Harvard University and colleagues showing that insulin-producing pancreatic beta cells can be created in a laboratory has reached the stage of commercialisation with the launch of a new company aimed at bringing a cell therapy for diabetes into human trials.